Search Results - "Ophthalmology (Rochester, Minn.)"

Refine Results
  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6

    C5 Inhibitor Avacincaptad Pegol for Geographic Atrophy Due to Age-Related Macular Degeneration: A Randomized Pivotal Phase 2/3 Trial by Jaffe, Glenn J, Westby, Keith, Csaky, Karl G, Monés, Jordi, Pearlman, Joel A, Patel, Sunil S, Joondeph, Brian C, Randolph, John, Masonson, Harvey, Rezaei, Kourous A

    Published in Ophthalmology (Rochester, Minn.) (01-04-2021)
    “…The complement pathway may play a key role in the pathogenesis of age-related macular degeneration (AMD). The safety and efficacy of avacincaptad pegol…”
    Get full text
    Journal Article
  7. 7
  8. 8
  9. 9

    Global Prevalence of Myopia and High Myopia and Temporal Trends from 2000 through 2050 by Holden, Brien A., PhD, DSc, Fricke, Timothy R., MSc, Wilson, David A., PhD, Jong, Monica, PhD, Naidoo, Kovin S., PhD, Sankaridurg, Padmaja, PhD, Wong, Tien Y., MD, Naduvilath, Thomas J., PhD, Resnikoff, Serge, MD

    Published in Ophthalmology (Rochester, Minn.) (01-05-2016)
    “…Purpose Myopia is a common cause of vision loss, with uncorrected myopia the leading cause of distance vision impairment globally. Individual studies show…”
    Get full text
    Journal Article
  10. 10

    Efficacy of a Deep Learning System for Detecting Glaucomatous Optic Neuropathy Based on Color Fundus Photographs by Li, Zhixi, He, Yifan, Keel, Stuart, Meng, Wei, Chang, Robert T., He, Mingguang

    Published in Ophthalmology (Rochester, Minn.) (01-08-2018)
    “…To assess the performance of a deep learning algorithm for detecting referable glaucomatous optic neuropathy (GON) based on color fundus photographs. A deep…”
    Get full text
    Journal Article
  11. 11

    HAWK and HARRIER: Ninety-Six-Week Outcomes from the Phase 3 Trials of Brolucizumab for Neovascular Age-Related Macular Degeneration by Dugel, Pravin U, Singh, Rishi P, Koh, Adrian, Ogura, Yuichiro, Weissgerber, Georges, Gedif, Kinfemichael, Jaffe, Glenn J, Tadayoni, Ramin, Schmidt-Erfurth, Ursula, Holz, Frank G

    Published in Ophthalmology (Rochester, Minn.) (01-01-2021)
    “…To report the 96-week outcomes from HAWK and HARRIER. Phase 3, prospective, randomized, double-masked, multicenter studies comparing efficacy and safety of…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    Automated Identification of Diabetic Retinopathy Using Deep Learning by Gargeya, Rishab, Leng, Theodore, MD, MS

    Published in Ophthalmology (Rochester, Minn.) (01-07-2017)
    “…Purpose Diabetic retinopathy (DR) is one of the leading causes of preventable blindness globally. Performing retinal screening examinations on all diabetic…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Accuracy of Intraocular Lens Calculation Formulas by Melles, Ronald B., Holladay, Jack T., Chang, William J.

    Published in Ophthalmology (Rochester, Minn.) (01-02-2018)
    “…To compare the accuracy of intraocular lens (IOL) calculation formulas (Barrett Universal II, Haigis, Hoffer Q, Holladay 1, Holladay 2, Olsen, and SRK/T) in…”
    Get full text
    Journal Article
  20. 20

    Global Prevalence of Presbyopia and Vision Impairment from Uncorrected Presbyopia: Systematic Review, Meta-analysis, and Modelling by Fricke, Timothy R, Tahhan, Nina, Resnikoff, Serge, Papas, Eric, Burnett, Anthea, Ho, Suit May, Naduvilath, Thomas, Naidoo, Kovin S

    Published in Ophthalmology (Rochester, Minn.) (01-10-2018)
    “…Presbyopia prevalence and spectacle-correction coverage were estimated by systematic review and meta-analysis of epidemiologic evidence, then modeled to expand…”
    Get full text
    Journal Article